1. Cancer statistics, 2022;Siegel;Ca - Cancer J. Clin.,2022
2. Characterization and validation of a ferroptosis-related LncRNA signature as a novel prognostic model for lung adenocarcinoma in tumor microenvironment;Wang;Front. Immunol.,2022
3. Efficacy and safety of Rezivertinib (BPI-7711) in patients with locally advanced or metastatic/recurrent EGFR T790M mutated NSCLC: a phase IIb study;Shi;J. Thorac. Oncol.,2022
4. Optimizing diagnosis and treatment of EGFR exon 20 insertions mutant NSCLC;Passiglia;Cancer Treat Rev.,2022
5. Relevance of multi-disciplinary team approach in diagnosis and management of Stage III NSCLC;Batra;Indian J. Cancer,2022